Inventor · disambiguated record
Kevin Nash
Also filed as: NASH KEVIN · NASH KEVIN R · NASH KEVIN RON
11 granted patents·6 pending applications·274 citations·filing 1999–2023
89Inventor score
Top patents by PatentIndex Score
17 records- 0195US7094604B2Production of pseudotyped recombinant AAV virionsUNIV FLORIDA·Filed 2004·Granted Aug 22, 2006·214 cites·35 claims
- 0280US7687510B2Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processesBAYER HEALTHCARE AG·Filed 2003·Granted Mar 30, 2010·17 cites·23 claims
- 0379US7566723B21-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their useBAYER HEALTHCARE AG·Filed 2003·Granted Jul 28, 2009·14 cites·11 claims
- 0477US7691854B2Dihydropyridine derivatives for use as human neutrophil elastase inhibitorsBAYER SCHERING PHARMA AG·Filed 2003·Granted Apr 6, 2010·13 cites·17 claims
- 0574US7199136B21,4-dihydro-1,4-diphenylpyridine derivativesBAYER HEALTHCARE AG·Filed 2002·Granted Apr 3, 2007·8 cites·15 claims
- 0669US2024216536A1Secreted ube3a for treatment of neurological disordersUNIV SOUTH FLORIDA·Filed 2023·Application pending·0 cites
- 0767US11534500B2Modified UBE3A gene for a gene therapy approach for angelman syndromeUNIV SOUTH FLORIDA·Filed 2017·Granted Dec 27, 2022·1 cites·16 claims
- 0867US7230017B2Dihydropyridinone derivativesBAYER HEALTHCARE AG·Filed 2003·Granted Jun 12, 2007·4 cites·17 claims
- 0965US2023277684A1Modified ube3a gene for a gene therapy approach for angelman syndromeUNIV SOUTH FLORIDA·Filed 2022·Application pending·0 cites
- 1055US8173665B2I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their useGIELEN-HAERTWIG HEIKE·Filed 2009·Granted May 8, 2012·0 cites·12 claims
- 1153US2020113955A1Modified ube3a gene for a gene therapy approach for angelman syndromeNASH KEVIN RON·Filed 2019·Application pending·0 cites
- 1252US10435682B2Arginine deiminase gene therapy for disordered proteinsUNIV SOUTH FLORIDA·Filed 2017·Granted Oct 8, 2019·0 cites·8 claims
- 1349US2021130429A1Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseasesUNIV SOUTH FLORIDA·Filed 2020·Application pending·0 cites
- 1449US2022152223A1Vector and method for treating angelman syndromePTC THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1548US2023054593A1Methods of treating fragile x syndrome with reelinWEEBER EDWIN·Filed 2021·Application pending·0 cites
- 1639US10815285B2Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseasesGEMMA CARMELINA·Filed 2012·Granted Oct 27, 2020·0 cites·3 claims
- 1737US6900194B1Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseasesBAYER AG·Filed 1999·Granted May 31, 2005·3 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Nash files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →